Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)
- PMID: 28798889
- PMCID: PMC5548143
- DOI: 10.4172/2155-9562.1000423
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)
Abstract
Objective: To determine the relationships between hopelessness, depression, quality of life, and disease progression in ALS.
Methods: Hopelessness and depression were assessed prospectively in a cohort of people with ALS using the Beck Hopelessness scale (BHS) and the ALS Depression Inventory (ADI-12), respectively. ALS Specific Quality of Life and measures of functional status (ALSFRS-R and forced vital capacity) were collected. Associations between changes in psychological health and functional scores were calculated using Spearman correlation coefficients.
Results: Twenty-five people with ALS had at least 2 visits and were followed for a mean of 11 (± 6) months. People with hopelessness and depression reported worse quality of life (p<0.01 for both associations). Decline in function between any two visits measured by ALSFRS-R (p<0.01) and FVC (p=0.02) correlated with increased hopelessness, but not depression.
Conclusion: This study highlights the importance of monitoring hopelessness in ALS, particularly in patients with faster functional decline.
Keywords: Depression; Disease progression; Hopelessness; Predictor; Quality of life.
Figures
Similar articles
-
Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis.Aging Ment Health. 2020 Dec;24(12):1963-1967. doi: 10.1080/13607863.2019.1642296. Epub 2019 Jul 18. Aging Ment Health. 2020. PMID: 31317778
-
Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.Arch Phys Med Rehabil. 2017 Nov;98(11):2301-2307. doi: 10.1016/j.apmr.2017.04.004. Epub 2017 Apr 30. Arch Phys Med Rehabil. 2017. PMID: 28465220
-
Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression - A longitudinal study.Palliat Support Care. 2024 Oct;22(5):1150-1157. doi: 10.1017/S1478951523001347. Palliat Support Care. 2024. PMID: 37955056
-
Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes.Int J Clin Pract. 2019 Jan;73(1):e13257. doi: 10.1111/ijcp.13257. Epub 2018 Sep 19. Int J Clin Pract. 2019. PMID: 30230161
-
Psychological health in patients with amyotrophic lateral sclerosis.Amyotroph Lateral Scler. 2007 Aug;8(4):243-54. doi: 10.1080/17482960701374643. Amyotroph Lateral Scler. 2007. PMID: 17653923 Review.
Cited by
-
The illness experience for people with amyotrophic lateral sclerosis: A qualitative study.J Clin Nurs. 2021 May;30(9-10):1455-1463. doi: 10.1111/jocn.15697. Epub 2021 Feb 18. J Clin Nurs. 2021. PMID: 33559184 Free PMC article.
-
Alleviation of Psychological Distress and the Improvement of Quality of Life in Patients With Amyotrophic Lateral Sclerosis: Adaptation of a Short-Term Psychotherapeutic Intervention.Front Neurol. 2018 Apr 16;9:231. doi: 10.3389/fneur.2018.00231. eCollection 2018. Front Neurol. 2018. PMID: 29713302 Free PMC article.
-
The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers.Front Neurol. 2019 Mar 11;10:192. doi: 10.3389/fneur.2019.00192. eCollection 2019. Front Neurol. 2019. PMID: 30915018 Free PMC article. Review.
-
Quality of life and depression in patients with amyotrophic lateral sclerosis - does the country of origin matter?BMC Palliat Care. 2023 Jun 13;22(1):72. doi: 10.1186/s12904-023-01189-2. BMC Palliat Care. 2023. PMID: 37312136 Free PMC article.
-
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group.J Neurol. 2020 Jul;267(7):2130-2141. doi: 10.1007/s00415-020-09799-z. Epub 2020 Apr 7. J Neurol. 2020. PMID: 32266542
References
-
- Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, et al. Prevalence of depression in a 12 month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993–1001. - PubMed
-
- Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci. 1997;152:S75–79. - PubMed
-
- Kurt A, Nijboer F, Matuz T, Kubler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: Epidemiology and management. CNS Drugs. 2007;21:279–291. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous